The European Bank for Reconstruction and Development (EBRD) and the Dutch entrepreneurial development bank FMO have paid $5.4mn to acquire a 43.5% stake in Tajikistan’s leading micro lending institution, Imon International.
The move will allow Imon to continue providing financial services to more than 100,000 micro businesses and individual borrowers across the Central Asian nation despite the exit of Imon’s main shareholder, micro-credit Fund “IMON”. The EBRD and FMO will each own 17.9% of Imon, making another shareholder, Luxemburg-based Mikro Kapital, the largest shareholder with a stake of 42.7%.
The transaction also means Imon will comply with the regulatory requirements as well as international standards of corporate governance and integrity.
“Since 2008 we have been focused on the development of microfinance, and this shares purchase of Imon International fully fits into Mikro Kapital’s strategy,” Vincenzo Trani, president of Mikro Kapital, stated.
‘‘With this increased investment in Imon we focus on the future development of the financial institution. The target group of grassroots businesses and farmers that Imon supports is fully in line with FMO’s development objectives,” Jaap Reinking, FMO director of private equity, commented.
To date, the EBRD has invested €731mn through 139 projects in Tajikistan’s economy.
Related Articles
Kuwait sovereign fund sues over London skyscraper that threatens light access
Kuwait's sovereign wealth fund has initiated legal action against one of the City of London's largest development projects, claiming the planned 36-storey tower will obstruct light to a building it ... more
Russian state VTB Bank to divest non-core assets
Russia’s second-largest bank state-controlled VTB plans to divest non-core assets unrelated to banking operations within the next five years, according to Interfax citing the bank's CEO, ... more
Azerbaijani banks report mixed financial performance in Q1 2025
Azerbaijan’s leading commercial banks released their financial results for the first quarter of 2025, showing a mixed performance in profitability, digitalisation, credit growth and capital ... more
Most Read
-
Serbian biotech Dren Bio sold to Sanofi for $1.9bn
1 month ago
-
Scandal surrounding Hungarian central bank’s investments spreads to Polish developer GTC
30 days ago
-
Trump Ukraine envoy Witkoff dismisses Starmer’s Ukraine ceasefire plan, parrots Kremlin talking points
1 month ago
-
Israeli IDF troops engage in ground battle in Syria as airstrikes hit Palmyra
30 days ago
-
COMMENT: Why Iran remains wary of Trump's negotiation overtures
30 days ago